title: Introduction: Addressing the challenge of group B streptococcal disease.
authors: Novartis Vaccines and Diagnostics, Via Fiorentina 1, Siena, Italy. rino.rappuoli@novartis.com
authors: Rino
authors: R
authors: Rappuoli
authors: Steven
authors: S
authors: Black
mesh_terms: D005260:Female; D006801:Humans; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000382:microbiology*; D008581:Meningitis / Q000382:microbiology; D011247:Pregnancy; D018805:Sepsis / Q000382:microbiology; D013290:Streptococcal Infections / Q000276:immunology* / Q000517:prevention & control*; D022541:Streptococcal Vaccines / Q000276:immunology*; D013292:Streptococcus agalactiae / Q000276:immunology*
chemical_list: D022541:Streptococcal Vaccines